Trials / Completed
CompletedNCT06803290
Food Effect Study of VHX-896 in Healthy Volunteers
An Open-Label, Two-Period, Two-Sequence, Two-Treatment Randomized, Single Oral Dose, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetic Profile of VHX-896 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A single center, two-period, randomized study to evaluate the food effect of VHX-896 tablets in healthy volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VHX-896 | Oral tablet |
Timeline
- Start date
- 2022-06-21
- Primary completion
- 2022-12-27
- Completion
- 2022-12-27
- First posted
- 2025-01-31
- Last updated
- 2025-01-31
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06803290. Inclusion in this directory is not an endorsement.